Prestige Consumer Healthcare Inc (PBH) Holdings Boosted by Systematic Financial Management LP

Systematic Financial Management LP raised its position in Prestige Consumer Healthcare Inc (NYSE:PBH) by 23.3% during the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 45,290 shares of the company’s stock after buying an additional 8,570 shares during the quarter. Systematic Financial Management LP’s holdings in Prestige Consumer Healthcare were worth $1,355,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the business. South Dakota Investment Council lifted its position in shares of Prestige Consumer Healthcare by 8.6% in the 1st quarter. South Dakota Investment Council now owns 96,767 shares of the company’s stock worth $2,894,000 after purchasing an additional 7,700 shares during the period. Texas Permanent School Fund lifted its position in shares of Prestige Consumer Healthcare by 3.9% in the 1st quarter. Texas Permanent School Fund now owns 35,170 shares of the company’s stock worth $1,052,000 after purchasing an additional 1,313 shares during the period. Investment Management of Virginia LLC lifted its position in shares of Prestige Consumer Healthcare by 16.1% in the 1st quarter. Investment Management of Virginia LLC now owns 36,867 shares of the company’s stock worth $1,103,000 after purchasing an additional 5,102 shares during the period. Rhumbline Advisers lifted its position in shares of Prestige Consumer Healthcare by 1.2% in the 1st quarter. Rhumbline Advisers now owns 166,785 shares of the company’s stock worth $4,989,000 after purchasing an additional 1,967 shares during the period. Finally, Eagle Asset Management Inc. lifted its position in shares of Prestige Consumer Healthcare by 2.0% in the 1st quarter. Eagle Asset Management Inc. now owns 220,998 shares of the company’s stock worth $6,610,000 after purchasing an additional 4,244 shares during the period.

A number of research analysts have recently issued reports on PBH shares. Royal Bank of Canada restated a “buy” rating and issued a $97.00 price target on shares of Prestige Consumer Healthcare in a research report on Friday, March 15th. TheStreet downgraded shares of Prestige Consumer Healthcare from a “c” rating to a “d+” rating in a research report on Friday, May 10th. Desjardins downgraded shares of Prestige Consumer Healthcare to a “hold” rating and set a $88.00 price target on the stock. in a research report on Wednesday, February 13th. Zacks Investment Research upgraded shares of Prestige Consumer Healthcare from a “sell” rating to a “hold” rating in a research report on Wednesday, April 24th. Finally, ValuEngine upgraded shares of Prestige Consumer Healthcare from a “strong sell” rating to a “sell” rating in a research report on Monday, April 29th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. Prestige Consumer Healthcare presently has an average rating of “Hold” and an average price target of $54.07.

Shares of NYSE:PBH traded up $0.09 during mid-day trading on Friday, hitting $30.34. The company had a trading volume of 2,133 shares, compared to its average volume of 418,776. The firm has a market capitalization of $1.58 billion, a P/E ratio of 10.92, a P/E/G ratio of 1.74 and a beta of 0.96. The company has a quick ratio of 1.43, a current ratio of 2.37 and a debt-to-equity ratio of 1.64. Prestige Consumer Healthcare Inc has a one year low of $26.25 and a one year high of $41.76.

Prestige Consumer Healthcare (NYSE:PBH) last released its quarterly earnings data on Thursday, May 9th. The company reported $0.72 earnings per share for the quarter, beating the consensus estimate of $0.70 by $0.02. The company had revenue of $241.03 million during the quarter, compared to analyst estimates of $237.22 million. Prestige Consumer Healthcare had a negative net margin of 3.67% and a positive return on equity of 12.45%. Prestige Consumer Healthcare’s revenue for the quarter was down 5.8% compared to the same quarter last year. During the same quarter in the previous year, the business posted $0.62 EPS. On average, analysts anticipate that Prestige Consumer Healthcare Inc will post 2.81 EPS for the current fiscal year.

COPYRIGHT VIOLATION NOTICE: “Prestige Consumer Healthcare Inc (PBH) Holdings Boosted by Systematic Financial Management LP” was originally published by The Lincolnian Online and is the sole property of of The Lincolnian Online. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://www.thelincolnianonline.com/2019/05/17/prestige-consumer-healthcare-inc-pbh-holdings-boosted-by-systematic-financial-management-lp.html.

Prestige Consumer Healthcare Profile

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning.

Featured Story: What is an overbought condition?

Want to see what other hedge funds are holding PBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Prestige Consumer Healthcare Inc (NYSE:PBH).

Institutional Ownership by Quarter for Prestige Consumer Healthcare (NYSE:PBH)

Receive News & Ratings for Prestige Consumer Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Prestige Consumer Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.